Delisted and largely dumped by investors after a pair of restructurings failed to cure what ailed it, Cambridge, MA-based Helicos BioSciences ($HLCS) has stepped into bankruptcy court seeking Chapter 11 protection for the genomic sequencing company.
Starved of cash, Cambridge, MA-based Helicos BioSciences has cut its work force in half, laying off 40 people as it changes its focus to the diagnostics side of the business. The move earned a bit of
Deverlopers investigating new RNA interference therapies will soon have a new and powerful tool to aid their research work. Helicos BioScience reports that its scientists have mapped RNA without
With just enough money in the bank to make it into the first quarter of next year, Helicos BioSciences hired investment bank Thomas Weisel partners to help it hunt up some fresh cash. And new
The cancer center at Massachusetts General Hospital now has a genetic analysis system from Helicos Biosciences. The system incorporates a single-molecule sequencing technology--requiring no DNA
The Stanford engineer who founded Helicos Biosciences used the technology he helped create to sequence his own genome for less than $50,000. That's just a fraction of the $250,000 cost that had
Whatever else could be said about the controversial J. Craig Venter, you could never claim that the scientist thinks